CAS: 623172-56-5; Palmitoyl-L-Lysyl-L-Valyl-L-Lysine--2,2,2-Trifluoroacetic Acid (1/2)

该化合物是一种合成聚丙二酸衍生物,结合了棕榈酸和三聚二酸序列,稳定为三氟二烯二酸盐,这种改变增强了其溶性性和稳定性,使其适合于需要精确交付的配方;棕榈水会改善脂质薄膜的亲近性,促进皮肤渗透和生物活动;作为以浸渍为基础的化合物,生物医学和化妆品研究经常利用它来调节细胞过程的潜力,例如合金合成或细胞外基质调节;二氟二氟色盐形式确保高纯度和在实验或配方应用中持续性能;其结构允许有控制地释放和在生物化学研究中有针对性的活动.

英文名称Palmitoyl-L-Lysyl-L-Valyl-L-Lysine--2,2,2-Trifluoroacetic Acid (1/2)
中文名称棕榈酰三肽-5
IUPAC名称palmitoyl-L-lysyl-L-valyl-L-lysine--2,2,2-trifluoroacetic acid (1/2)
其它别名4Iv5Xo4Tgk; Palmtioyl Tripeptide-5; Palmitoyl Tripeptide-5 Bistrifluoracetate Salt; N2-(1-Oxohexadecyl)-L-Lysyl-L-Valyl-L-Lysine 2,2,2-Trifluoroacetate (1; Unii-4Iv5Xo4Tgk; Palmitoyl-L-Lysyl-L-Valyl-
CAS编号623172-56-5
MFCD编号:MFCD16621111
FDA UNII编号:4IV5XO4TGK
分子式:C37H67F6N5O9
分子量:839.96
产品CID: 2508406
产品分类生物化工 → 氨基酸及其衍生物 → 赖氨酸类衍生物

相似结构搜索
InChIKey: FKCOHLNFINRFFR-RROPMPDHSA-N
BSPABZINJHASIV-PRQXCCHZNA-N…
计算化学: 氢键受体数17.0氢键供体数8.0可旋转键数29.0

物理性质

PSA:261.71
LogP:10.1088
溶解性DMF: 30mg/mL; DMSO: 30mg/mL; Ethanol: 30mg/mL; Ethanol:Pbs (Ph 7.2) (1:3): 0.25mg/mL
外观形态结晶性固体
储存条件在惰性气体(氮气或氩气)下 2–8 °C
产品应用该化合物用作与可注射的碳酸类似的抗动和营养性化妆剂成分.

MSDS等安全信息

危险描述H302-H315-H319-H335

合成工艺路线路线简述

海关参考信息

2905121000-正丙醇
2905130000-正丁醇
2912110000-甲醛
2912120000-乙醛
💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
详情请参考：📖 海关编码查询和海关进出口税则

专利信息

专利号:US-8865651-B2
优先权日:2007-05-08
标题 :Cosmetic anti-ageing skin care compositions
发明人：OTTE STEPHANUS CORNELIS MARIA; ESTRADA HERNÃ NDEZ CLAUDIA AMALIA; WON ANNIS
权利人:OTTE STEPHANUS CORNELIS MARIA; ESTRADA HERNÃ NDEZ CLAUDIA AMALIA; WON ANNIS; TUPPERWARE PRODUCTS S A
摘要:The invention is directed to an anti ageing skin care composition, more in particular a cosmetic anti aging skin care composition. The anti ageing skin care composition of the invention comprise, in a physiologically acceptable medium, (i) at least one peptide from Laminin-1 that is able to promote synthesis of Laminin-5; (ii) at least one peptide capable of at least partially inhibiting neuronal exocytosis; and (iii) at least one tripeptide producing a rapid and strong stimulation of collagen synthesis. The compositions of the present invention are effective in reducing existing wrinkles and/or preventing the formation of new wrinkles.